Shares

5 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2022

May 09, 2022

SELL
$126.46 - $235.05 $206,762 - $384,306
-1,635 Closed
0 $0
Q4 2021

Feb 14, 2022

BUY
$225.82 - $368.51 $75,423 - $123,082
334 Added 25.67%
1,635 $415,000
Q3 2021

Nov 12, 2021

BUY
$221.9 - $484.47 $37,057 - $80,906
167 Added 14.73%
1,301 $499,000
Q2 2021

Jul 29, 2021

SELL
$129.91 - $234.98 $73,788 - $133,468
-568 Reduced 33.37%
1,134 $266,000
Q1 2021

Apr 29, 2021

BUY
$109.18 - $185.98 $185,824 - $316,537
1,702 New
1,702 $223,000

Others Institutions Holding MRNA

About Moderna, Inc.


  • Ticker MRNA
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 391,200,000
  • Market Cap $45.4B
  • Description
  • Moderna, Inc., a biotechnology company, discovers, develops, and commercializes messenger RNA therapeutics and vaccines for the treatment of infectious diseases, immuno-oncology, rare diseases, cardiovascular diseases, and auto-immune diseases in the United States, Europe, and internationally. Its respiratory vaccines include COVID-19, flu, resp...
More about MRNA
Track This Portfolio

Track Perennial Investment Advisors, LLC Portfolio

Follow Perennial Investment Advisors, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Perennial Investment Advisors, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Perennial Investment Advisors, LLC with notifications on news.